Discontinuing psychotropic agents

Baldessarini R J (1996) Drugs and the treatment of psychiatric disorders. In Hardman J G , Limbird L E , Molino¡ P B , Ruddon R W , Gilman AG (eds), Goodman and Gilman's the pharmacological basis of therapeutics, 9th edn. McGraw-Hill, New York, pp. 399–459

Baldessarini R J , Tondo L (1998) E¡ects of lithium treatment in bipolar disorders and post-treatment-discontinuation recurrence risk. Clin Drug Invest 15: 337–351

Baldessarini R J , Suppes T , Tondo L (1996) Lithium withdrawal in bipolar disorder: implications for clinical practice and experimental therapeutics research. Am J Therapeut 3: 492–496

Healy D , Tranter R (1999) Pharmacological stress diathesis syndromes. J Psychopharmacol 13: 287–290

Hyman S E , Nestler E J (1996) Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry 153: 151–162

Rosenbaum J , Fava M , Hoog S L , Ascroft R C , Krebs W B (1998) Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry 44: 77–87

Tondo L , Baldessarini R J , Floris G , Silvetti F , Hennen, J , Tohen M , Rudas N (1998) Lithium treatment reduces risk of suicidal behavior in bipolar disorder patients. JClin Psychiatry 59: 405–414

Viguera AC , Baldessarini R J , Hegarty J M , Van Kammen D , Tohen M (1997) Risk of discontinuing maintenance medication in schizophrenia. Arch Gen Psychiatry 54: 49–55

Viguera AC , Baldessarini R J , Friedberg J (1998) Risks of interrupting continuation or maintenance treatment with antidepressants in major depressive disorders. Harvard Rev Psychiatry 5: 293–306